EUVIMEDEUVIMED entdecken
Open Access

A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy

Erbao Chen, Yuqian Mo, Jing Yi, Jie Liu, Ting Luo, Zheng Li, Zewei Lin, Yibing Hu, Zhilin Zou, Jikui Liu

Aging · 2023

DOI: 10.18632/aging.204862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Erbao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansPrognosisCarcinogenesisImmunotherapyMechanistic Target of Rapamycin Complex 1Fatty Acid-Binding ProteinsMembrane ProteinsAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

hepatocellular carcinomaimmunotherapymTORC1prognosistumor microenvironment

Substanzen

Mechanistic Target of Rapamycin Complex 1FABP5 protein, humanFatty Acid-Binding ProteinsPAG1 protein, humanMembrane ProteinsAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • School of Public Health, Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Operating Room, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Department of Ophthalmology, Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.

Zitieren

APA

Chen, E., Mo, Y., Yi, J., Liu, J., Luo, T., Li, Z., Lin, Z., Hu, Y., Zou, Z., & Liu, J. (2023). A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy. Aging. https://doi.org/10.18632/aging.204862

Vancouver

Chen E, Mo Y, Yi J, Liu J, Luo T, Li Z, et al. A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy. Aging. 2023. doi:10.18632/aging.204862

BibTeX
@article{Chen2023,
  author = {Chen, Erbao and Mo, Yuqian and Yi, Jing and Liu, Jie and Luo, Ting and Li, Zheng and Lin, Zewei and Hu, Yibing and Zou, Zhilin and Liu, Jikui},
  title = {A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204862}
}
Kostenlos starten →